RELATED CONTENT
NEWS
- FDA panel: Benefits of Bayer's Yaz/Yasmin outweigh risks, but labels need revision
- Lupin set for first launch in US generic oral contraceptive market
- Watson launches generic contraceptive in midst of Yaz controversy
- US Capitol Capsule: Supreme Court takes another stab at refining US patent law
FEATURES
Other Informa Features
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK

Section Head (m/f)
DRA International/CIS Section

Section Head (m/f)
DRA International/CIS Section

